Saba Molhemi

Mr. Saba Molhemi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
EWEmil Westi
Emil Westi
SMSaba Molhemi
Saba Molhemi
CHCaroline Termøhlen Hansen
Caroline Termøhlen Hansen
CSChristian Stald Skoven
Christian Stald Skoven
RKRasmus West Knopper
Rasmus West Knopper
BABlanca Irene Aldana
Blanca Irene Aldana
Alzheimer’s disease (AD) is characterized by complex interactions between neuropathological markers, metabolic dysregulation, and structural brain changes. In this study, we utilized a multimodal approach, combining immunohistochemistry, functional metabolic mapping, and microstructure sensitive diffusion MRI (dMRI) to progressively investigate these interactions in the 5xFAD mouse model of AD. Our analysis revealed age-dependent and region-specific accumulation of key AD markers, including amyloid-beta (Aβ), GFAP, and IBA1, with significant differences observed between the hippocampal formation and upper and lower regions of the cortex by 6 months of age. Functional metabolic mapping validated localized disruptions in energy metabolism, with glucose hypometabolism in the hippocampus and impaired astrocytic metabolism in the cortex. Notably, increased cortical glutaminolysis suggested a shift in microglial metabolism, reflecting an adaptive response to neuroinflammatory processes. While dMRI showed no significant microstructural differences between 5xFAD and wild-type controls, the study highlights the importance of metabolic alterations as critical events in AD pathology. These findings emphasize the need for targeted therapeutic strategies addressing specific metabolic disturbances and underscore the potential of integrating advanced imaging with metabolic and molecular analyses to advance our understanding of AD progression.

30 December 2024 in HardwareX
Verified
Journal Article
Open access
SMSaba Molhemi
Saba Molhemi
LØLeif Østergaard
Leif Østergaard
BHBrian Hansen
Brian Hansen
Awake mouse MRI and spectroscopy (MRS) are valuable techniques for studying biological questions without the confounding effects of anaesthesia. Currently, no off-the-shelf solution exists for awake mouse MRI/S. To address this, we present a Mouse Cradle Suspension System (MCSS) for awake mouse MRI/S. Our design is freely available and offers a low-cost 3D-printed setup compatible with a Bruker Biospec 94/20 scanner and commercially available 1H/31P surface- and volume-coils, such as coils from Bruker Biospin (T20025V3) and Rapid (O-XL-HL-094). While the focus here is measurements in awake mouse brain, the coils and the presented setup is suitable for both mouse and rat brain, and studies of mouse body organs. Moreover, the design is easily modifiable to suit other applications and hardware configurations. The MCSS reduces gradient-induced coil vibrations and supports cross-coil setups. It features an inner and outer rail system for easy insertion of the coil and customized mouse cradle into the scanner. The cradle is suitable for both anaesthetized and awake mouse scans and existing habituation protocols for awake mouse MRI/S. This MCSS design ensures a smooth workflow for awake mouse MRI/S. The cost is approximately 200€, achieved using 3D-printed and off-the-shelf components.

14 November 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SMSaba Molhemi
Saba Molhemi
RKRasmus West Knopper
Rasmus West Knopper
CSChristian Stald Skoven
Christian Stald Skoven
TLThomas Beck Lindhardt
Thomas Beck Lindhardt
CDCaroline Degel
Caroline Degel
BHBrian Hansen
Brian Hansen
Normal brain function hinges on energy-intensive processes. Consequently, alterations to the brain’s metabolic state are common hallmarks in several pathological conditions. Phosphorus Magnetic Resonance Spectroscopy ( 31 P MRS) is a noninvasive method for measuring key markers of brain energy metabolism, including adenosine triphosphate (ATP), inorganic phosphate (Pi), and phosphocreatine (PCr), as well as markers for cell membrane phospholipid turnover, phosphomonoester (PME) and phosphodiester (PDE). Preclinical rodent 31 P MRS has so far been done under anesthesia - with isoflurane being one of the most commonly used anesthetic agents. The use of isoflurane in 31 P MRS is a concern, as anesthetics are known to affect neuronal activity and energy metabolism in the brain. Its use therefore comes with a risk of perturbing brain physiology. Awake mouse MRS avoids this and allows the effect of isoflurane to be quantified. Thus, we here compare mouse brain 31 P MRS in awake MR-habituated mice and isoflurane anesthesia. We find that 31 P metabolite levels differ between the awake state and isoflurane anesthesia in mice. Our findings show that low-dose isoflurane anesthesia reduces PCr levels in the mouse brain and is accompanied by decreases in intracellular pH and decreased PME levels.